Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03131466Completed
Randomised, single-blind trial (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Effective rate of Primary Trigeminal Neuralgia treatment at 1 year. Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03131466.